Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tilray

Up 55% in the Last Week, is Tilray Still a Buy?

Cannabis producer Tilray's (TLRY) shares soared last week on hopes of the passage of a marijuana legalization bill. However, some experts believe the bill is unlikely to garner sufficient support for passage in its current form. So, will the stock be able to maintain its newfound momentum in the near…

StockNews.com

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Falling

Shares of many cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga

Simon Says Legalize: Tilray CEO Makes The Case For Cannabis

Cannabis stocks continue to rise Friday following reports the U.S. House Rules Committee plans to meet next week to prepare a federal marijuana legalization bill for floor action.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Tilray Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Tilray (NASDAQ:TLRY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Rising

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Popping Off

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga

Why Tilray, Canopy Growth Look Set For New Highs Despite Failing To Hold After-Hours Surge

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) gapped up slightly higher on Wednesday after running up to 7.43% and 12.87%, respectively, in the after-hours trading session on Tuesday.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What 4 Analyst Ratings Have To Say About Tilray

Tilray (NASDAQ:TLRY) has observed the following analyst ratings within the last quarter:

Benzinga

Tilray Poised To Conquer Malta's Medical Marijuana Market - Launches First Medical Cannabis Oil

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) confrimed Thursday that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offering and launched the first EU GMP medical cannabis oil products in Malta.

Benzinga

Irwin Simon, At The Helm Of One Of The Biggest Cannabis Operators, Tilray: Meet Our Keynote Speakers

Who is the person behind the largest Canadian cannabis company in the world? That would be Irwin D. Simon, chairman and CEO of Tilray Brands Inc. (NASDAQ: TLRY).

Benzinga

HEXO Elects Seven Directors At Its Shareholders Meeting On The Heels Of Tilray Deal

HEXO Corp. (NASDAQ: HEXO) (TSX:HEXO) elected seven directors at the annual general and special meeting of shareholders held on March 8, 2022.

Benzinga

What Does Tilray Get From HEXO Debt Deal? Analyst Says 'Chapeau!' To CEO Irwin Simon

On Thursday, HEXO Corp. (NASDAQ: HEXO) finalized a strategic partnership with Tilray Brands, Inc.

Benzinga

Tilray Continues To Crash After Partnership Announcement: What's Next?

Tilray Inc. (NASDAQ: TLRY) shares are trading lower Thursday and are continuing the downward trend the stock has been on.

Benzinga

Why HEXO Shares Are Trading Higher Today

HEXO Corp (NASDAQ: HEXO) is trading higher Thursday after the company announced a strategic partnership with Tilray Brands Inc (NASDAQ: TLRY) which includes a new debt financing agreement.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Chart Wars: Between Sundial And Tilray, Which Marijuana Stock Could Smoke Shorts First?

Sundial Growers Inc (NASDAQ: SNDL) was trading slightly higher on Wednesday, while Tilray, Inc (NASDAQ: TLRY) was trading down about 2%.

Benzinga

Tilray's Subsidiary Manitoba Harvest To Present Its New Product Line 'Power Of Hemp'

Tilray's (NASDAQ: TLRY) subsidiary Manitoba Harvest, a hemp foods brand will unveil its new product lineup at the upcoming Natural Products Expo West, to be held March 10-12 in Anaheim, CA.

Benzinga

Aurora Cannabis Is Selling Stock To Pay Off Debt: Why Tilray And Canopy Could Be Next In Line

Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slig

Benzinga

Where Will Tilray's Stock Be In 2025? Survey Says...

Tilray Inc (NASDAQ: TLRY), a Canadian pharmaceutical and cannabis company, is one of the most popular cannabis stocks out there. Back in 2018, the stock ran all the way to $148 before coming back down to the single digits.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified

Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed Ana Bowman as a chief financial officer, effective February 22.

Benzinga

Tilray Launches Medical Cannabis Products In Malta

Tilray Brands, Inc.

Benzinga

Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey

This article was originally published on Cannabis.net and appears here with permission.

Benzinga

The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents

Benzinga

Tilray Stock Is Having A Green Day: What's Going On?

Tilray Inc.

Benzinga

Tilray Consolidates Its Portfolio Of Brands & Products Into Tilray Medical

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced the launch of Tilray Medical, a global medical platform

Benzinga

Chart Wars: Between Tilray And Canopy Growth, Which Cannabis Stock Could Slam Shorts Harder?

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) soared 10.59% and 8.76%, respectively, on Monday.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Canopy Growth Corporation

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.